Peripherally Inserted Internal Jugular Catheters: an Observational Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03523533|
Recruitment Status : Recruiting
First Posted : May 14, 2018
Last Update Posted : September 30, 2019
|Condition or disease||Intervention/treatment||Phase|
|Intravenous Drug Usage||Procedure: Angiocatheter||Not Applicable|
This is an observational study with one arm. All enrolled patients will receive a peripheral angiocatheter in the internal jugular vein. Approximately 60 subjects will be enrolled.
After recruitment and consent, an investigator will place the peripherally-inserted jugular (PIJ) catheters for this study, under ultrasound guidance. Clean technique similar to that used for traditional peripheral intravenous catheters will be used, including chlorhexidine skin preparation, caps, and sterile ultrasound gel with sterile occlusive dressing over the ultrasound transducer. For patients included in this study because of a clinically-determined need for a second IV line, the catheter will be placed after anesthesia induction. Patients included because of difficult IV access will have the PIJ catheter placed prior to induction.
The size of the angiocatheter will be left to the clinical discretion of the investigator, from among these choices: 18G x 2.5 inches, 16G x 2 inches, or 14G x 2 inches. All angiocatheters will be radiopaque in order to permit visualization in the event of any required imaging. Catheters will be placed with visualization under dynamic ultrasonography using a Sonosite S-Nerve ultrasound machine with 13-6 MHz 25 mm linear array. All catheters and ultrasound components are being used in accordance with their labeling.
The depth of catheter insertion into the internal jugular vein will be determined, and the catheter will be removed/replaced immediately if it is found to extend less than 1.0 cm into the vessel. If the catheter is removed or replaced, routine care will be followed: pressure will be held until bleeding subsides and the site dressed appropriately (e.g. gauze with tape or adhesive bandage). No more than three attempts will be made before abandoning the effort to place a PIJ catheter.
The PIJ catheter will be secured as per normal practice, with an adhesive IV securing device and an occlusive bandage placed over both the IV and its securing device.
The PIJ catheter will be used as usual during surgery. It will not be used for total parenteral nutrition or other continuous nutrient infusions.
In most cases, the PIJ catheter will be removed as usual before the patient is transferred to the floor, intensive care unit, or discharged home. In some cases, however, an appropriately authorized clinician may determine that the PIJ catheter should remain in place longer. If extended use of the PIJ catheter is indicated, it will be removed when it is either replaced as appropriate by another intravenous line or no longer needed.
Procedural data will be gathered on the day of surgery, and chart review will occur after surgery in order to capture any IV-related complications within the first week that were not immediately apparent.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||60 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||This is an observational study.|
|Masking:||None (Open Label)|
|Official Title:||Peripherally Inserted Internal Jugular Catheters: an Observational Study|
|Actual Study Start Date :||August 3, 2018|
|Estimated Primary Completion Date :||December 2019|
|Estimated Study Completion Date :||December 2019|
Experimental: Peripherally-inserted internal jugular catheter
All enrolled patients will receive a peripheral angiocatheter in the internal jugular vein, under dynamic ultrasound guidance.
Placement of angiocatheter in internal jugular vein
- Catheter placement time [ Time Frame: No more than 20 minutes ]Elapsed time from first contact of skin prep solution to completely secured/covered catheter
- Location of insertion [ Time Frame: No more than 20 minutes ]Choice of placement on patient's right or left side
- Depth of insertion [ Time Frame: No more than 20 minutes ]Depth of catheter insertion in target blood vessel
- Number of attempts [ Time Frame: No more than 20 minutes ]Count of attempts to successfully place catheter
- Incidence of complications [ Time Frame: 1 week ]Count of complications that are related to catheter placement
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03523533
|Contact: Tony Yen, MDemail@example.com|
|Contact: Timothy Petersen, PhDfirstname.lastname@example.org|
|United States, New Mexico|
|University of New Mexico Hospital||Recruiting|
|Albuquerque, New Mexico, United States, 87106|
|Contact: Tony Yen, MD 505-272-2610|
|Principal Investigator:||Tony Yen, MD||University of New Mexico Health Sciences Center (HSC)|